Sign In

Login

Password

Forgot Password ? Sign Up

PCSK9 (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "PCSK9" in German language version.

refsWebsite
Global rank German rank
10doi.org
2nd place
3rd place
10nih.gov
4th place
7th place
5zdb-katalog.de
123rd place
6th place
3web.archive.org
1st place
1st place
2europa.eu
68th place
29th place
2themedicinescompany.com
low place
low place
1sciencedirect.com
149th place
298th place
1zeit.de
267th place
15th place
1archive.today
14th place
31st place
1fda.gov
447th place
751st place
1medscape.com
719th place
1,553rd place
1pfizer.com
low place
low place
1alnylam.com
low place
low place

alnylam.com

archive.today

doi.org

  • G. Lambert, B. Sjouke, B. Choque, J. J. Kastelein, G. K. Hovingh: The PCSK9 decade. In: Journal of lipid research. Band 53, Nummer 12, Dezember 2012, ISSN 0022-2275, S. 2515–2524, doi:10.1194/jlr.R026658, PMID 22811413, PMC 3494258 (freier Volltext).
  • F. R. Maxfield, G. van Meer: Cholesterol, the central lipid of mammalian cells. In: Current opinion in cell biology. Band 22, Nummer 4, August 2010, ISSN 1879-0410, S. 422–429, doi:10.1016/j.ceb.2010.05.004, PMID 20627678, PMC 2910236 (freier Volltext).
  • N. G. Seidah, M. S. Sadr, M. Chrétien, M. Mbikay: The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions. In: The Journal of biological chemistry. Band 288, Nummer 30, Juli 2013, ISSN 1083-351X, S. 21473–21481, doi:10.1074/jbc.R113.481549, PMID 23775089, PMC 3724608 (freier Volltext).
  • F. Petrides, K. Shearston, M. Chatelais, F. Guilbaud, O. Meilhac, G. Lambert: The promises of PCSK9 inhibition. In: Current opinion in lipidology. Band 24, Nummer 4, August 2013, ISSN 1473-6535, S. 307–312, doi:10.1097/MOL.0b013e328361f62d, PMID 23817198.
  • M. Abifadel, M. Varret, J. P. Rabès, D. Allard, K. Ouguerram, M. Devillers, C. Cruaud, S. Benjannet, L. Wickham, D. Erlich, A. Derré, L. Villéger, M. Farnier, I. Beucler, E. Bruckert, J. Chambaz, B. Chanu, J. M. Lecerf, G. Luc, P. Moulin, J. Weissenbach, A. Prat, M. Krempf, C. Junien, N. G. Seidah, C. Boileau: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. In: Nature genetics. Band 34, Nummer 2, Juni 2003, ISSN 1061-4036, S. 154–156, doi:10.1038/ng1161, PMID 12730697.
  • Jonathan C. Cohen, Eric Boerwinkle, Thomas H. Mosley, Helen H. Hobbs: Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease. In: New England Journal of Medicine. Band 354, Nr. 12, 2006, S. 1264–1272, doi:10.1056/NEJMoa054013, PMID 16554528.
  • Jonathan C. Cohen, Helen H. Hobbs: Simple Genetics for a Complex Disease. In: Science. Band 340, Nr. 6133, 5. Oktober 2013, S. 689–690, doi:10.1126/science.1239101, PMID 23661745.
  • X. D. Xia, Z. S. Peng, H. M. Gu, M. Wang, G. Q. Wang, D. W. Zhang: Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications. In: Frontiers in cardiovascular medicine. Band 8, 2021, S. 764038, doi:10.3389/fcvm.2021.764038, PMID 34782856, PMC 8589637 (freier Volltext) (Review).
  • P. Lebeau, K. Platko et al.: Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained. In: Journal of Biological Chemistry. Band 293, Nummer 19, Mai 2018, S. 7329–7343, doi:10.1074/jbc.RA117.001049, PMID 29593095, PMC 5950004 (freier Volltext).
  • S. T. Kent, R. S. Rosenson et al.: Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites. In: Circulation. Cardiovascular genetics. Band 10, Nummer 4, August 2017, S. e001632, doi:10.1161/CIRCGENETICS.116.001632, PMID 28768753, PMC 5729040 (freier Volltext).

europa.eu

ema.europa.eu

fda.gov

medscape.com

deutsch.medscape.com

nih.gov

ncbi.nlm.nih.gov

  • G. Lambert, B. Sjouke, B. Choque, J. J. Kastelein, G. K. Hovingh: The PCSK9 decade. In: Journal of lipid research. Band 53, Nummer 12, Dezember 2012, ISSN 0022-2275, S. 2515–2524, doi:10.1194/jlr.R026658, PMID 22811413, PMC 3494258 (freier Volltext).
  • F. R. Maxfield, G. van Meer: Cholesterol, the central lipid of mammalian cells. In: Current opinion in cell biology. Band 22, Nummer 4, August 2010, ISSN 1879-0410, S. 422–429, doi:10.1016/j.ceb.2010.05.004, PMID 20627678, PMC 2910236 (freier Volltext).
  • N. G. Seidah, M. S. Sadr, M. Chrétien, M. Mbikay: The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions. In: The Journal of biological chemistry. Band 288, Nummer 30, Juli 2013, ISSN 1083-351X, S. 21473–21481, doi:10.1074/jbc.R113.481549, PMID 23775089, PMC 3724608 (freier Volltext).
  • F. Petrides, K. Shearston, M. Chatelais, F. Guilbaud, O. Meilhac, G. Lambert: The promises of PCSK9 inhibition. In: Current opinion in lipidology. Band 24, Nummer 4, August 2013, ISSN 1473-6535, S. 307–312, doi:10.1097/MOL.0b013e328361f62d, PMID 23817198.
  • M. Abifadel, M. Varret, J. P. Rabès, D. Allard, K. Ouguerram, M. Devillers, C. Cruaud, S. Benjannet, L. Wickham, D. Erlich, A. Derré, L. Villéger, M. Farnier, I. Beucler, E. Bruckert, J. Chambaz, B. Chanu, J. M. Lecerf, G. Luc, P. Moulin, J. Weissenbach, A. Prat, M. Krempf, C. Junien, N. G. Seidah, C. Boileau: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. In: Nature genetics. Band 34, Nummer 2, Juni 2003, ISSN 1061-4036, S. 154–156, doi:10.1038/ng1161, PMID 12730697.
  • Jonathan C. Cohen, Eric Boerwinkle, Thomas H. Mosley, Helen H. Hobbs: Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease. In: New England Journal of Medicine. Band 354, Nr. 12, 2006, S. 1264–1272, doi:10.1056/NEJMoa054013, PMID 16554528.
  • Jonathan C. Cohen, Helen H. Hobbs: Simple Genetics for a Complex Disease. In: Science. Band 340, Nr. 6133, 5. Oktober 2013, S. 689–690, doi:10.1126/science.1239101, PMID 23661745.
  • X. D. Xia, Z. S. Peng, H. M. Gu, M. Wang, G. Q. Wang, D. W. Zhang: Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications. In: Frontiers in cardiovascular medicine. Band 8, 2021, S. 764038, doi:10.3389/fcvm.2021.764038, PMID 34782856, PMC 8589637 (freier Volltext) (Review).
  • P. Lebeau, K. Platko et al.: Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained. In: Journal of Biological Chemistry. Band 293, Nummer 19, Mai 2018, S. 7329–7343, doi:10.1074/jbc.RA117.001049, PMID 29593095, PMC 5950004 (freier Volltext).
  • S. T. Kent, R. S. Rosenson et al.: Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites. In: Circulation. Cardiovascular genetics. Band 10, Nummer 4, August 2017, S. e001632, doi:10.1161/CIRCGENETICS.116.001632, PMID 28768753, PMC 5729040 (freier Volltext).

pfizer.com

sciencedirect.com

themedicinescompany.com

ir.themedicinescompany.com

themedicinescompany.com

web.archive.org

zdb-katalog.de

  • G. Lambert, B. Sjouke, B. Choque, J. J. Kastelein, G. K. Hovingh: The PCSK9 decade. In: Journal of lipid research. Band 53, Nummer 12, Dezember 2012, ISSN 0022-2275, S. 2515–2524, doi:10.1194/jlr.R026658, PMID 22811413, PMC 3494258 (freier Volltext).
  • F. R. Maxfield, G. van Meer: Cholesterol, the central lipid of mammalian cells. In: Current opinion in cell biology. Band 22, Nummer 4, August 2010, ISSN 1879-0410, S. 422–429, doi:10.1016/j.ceb.2010.05.004, PMID 20627678, PMC 2910236 (freier Volltext).
  • N. G. Seidah, M. S. Sadr, M. Chrétien, M. Mbikay: The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions. In: The Journal of biological chemistry. Band 288, Nummer 30, Juli 2013, ISSN 1083-351X, S. 21473–21481, doi:10.1074/jbc.R113.481549, PMID 23775089, PMC 3724608 (freier Volltext).
  • F. Petrides, K. Shearston, M. Chatelais, F. Guilbaud, O. Meilhac, G. Lambert: The promises of PCSK9 inhibition. In: Current opinion in lipidology. Band 24, Nummer 4, August 2013, ISSN 1473-6535, S. 307–312, doi:10.1097/MOL.0b013e328361f62d, PMID 23817198.
  • M. Abifadel, M. Varret, J. P. Rabès, D. Allard, K. Ouguerram, M. Devillers, C. Cruaud, S. Benjannet, L. Wickham, D. Erlich, A. Derré, L. Villéger, M. Farnier, I. Beucler, E. Bruckert, J. Chambaz, B. Chanu, J. M. Lecerf, G. Luc, P. Moulin, J. Weissenbach, A. Prat, M. Krempf, C. Junien, N. G. Seidah, C. Boileau: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. In: Nature genetics. Band 34, Nummer 2, Juni 2003, ISSN 1061-4036, S. 154–156, doi:10.1038/ng1161, PMID 12730697.

zeit.de